Table 5.
Comparison of clinical and pathological features and miR-145 and miR-205 relative expression levels among 84 cervical cancer patients (x̅ ± sd)
| Category | Case | miR-145 | T | P | miR-205 | t | P |
|---|---|---|---|---|---|---|---|
| Age | 0.573 | 0.568 | 0.241 | 0.810 | |||
| ≥50 years | 48 | 0.412±0.254 | 1.244±0.349 | ||||
| <50 years | 36 | 0.442±0.213 | 1.262±0.323 | ||||
| Pathological type | 0.099 | 0.921 | 0.250 | 0.803 | |||
| Squamous cell carcinoma | 75 | 0.425±0.259 | 1.238±0.342 | ||||
| Adenocarcinoma | 9 | 0.434±0.241 | 1.268±0.324 | ||||
| Tumor volume | 3.928 | <0.001 | 3.937 | <0.001 | |||
| ≥5 cm | 49 | 0.325±0.178 | 1.426±0.398 | ||||
| <5 cm | 35 | 0.521±0.279 | 1.124±0.257 | ||||
| Histological grade | 0.691 | 0.492 | 1.642 | 0.105 | |||
| Well-differentiated | 18 | 0.439±0.264 | 1.196±0.287 | ||||
| Moderately- and poorly-differentiated | 66 | 0.399±0.204 | 1.352±0.374 | ||||
| Parauterine invasion | 2.567 | 0.012 | 2.570 | 0.012 | |||
| Yes | 15 | 0.315±0.186 | 1.389±0.373 | ||||
| No | 69 | 0.513±0.284 | 1.168±0.285 | ||||
| FIGO staging | 3.217 | 0.002 | 3.472 | <0.001 | |||
| I-II | 68 | 0.547±0.297 | 1.154±0.269 | ||||
| III-IV | 16 | 0.307±0.178 | 1.439±0.371 | ||||
| Lymphatic metastasis | 3.439 | <0.001 | 4.115 | <0.001 | |||
| Yes | 64 | 0.529±0.257 | 1.162±0.254 | ||||
| No | 20 | 0.315±0.189 | 1.468±0.387 |
Note: miR-145, miRNA-145; miR-205, miRNA-205.